Indeed, the serum ET-1 level was correlated with distant metastasis in NPC patients [8], and the ETAR inhibitor ABT-627 was found to inhibit the experimental metastasis of NPC cells [9]. Here, EDN1 is linked to nasopharyngeal carcinoma.